C14H11NO 2 , monoclinic, P21/c (no. 14), a = 12.7731(19) Å,
T = 298(2) K.
CCDC no.: 1903701
The molecular structure of the title crystal structure is shown in the figure (atoms are drawn with arbitrary radii). Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.
Source of material
The title compound was obtained according to the literature method [5] . Single crystal suitable for X-ray diffraction were grown during slow evaporation of a mixture of ethyl acetate and petroleum ether.
Experimental details
H atoms bonded were positioned geometrically and refined using a riding model, with C-H = 0.93/0.96/0.97 Å and N-H = 0.86 Å with U iso = 1.2 times Ueq(C) and 1.2 times Ueq(N). 
Discussion
In recent years, phenanthridinone has been found to be a key core unit in some natural products with important biological activities [6] [7] [8] and drug molecules for the treatment of nerve diseases [9] [10] [11] . Thus, the synthesis and crystal structures of various phenanthridinone derivatives have attracted great attention [5, 12] . There is one molecule in the asymmetric unit. In the title compound, the two benzo rings and the pyridin-2(1H)-one ring are in the same plane, indicating the compound is an almost planar molecule. This planar parent structure is also present in the previously reported phenanthridinone derivatives [5, 13] . The molecules of the title compound in the same layer are connected by N(1)-H(1)· · · O(1) hydrogen bonds (donor-acceptor distance: 2.829 Å), which is in agreement with that in previously reported structure of phenanthridone [13] . The molecules in the next layers are stabilized by two kinds of aromatic C-H· · · π (2.805 and 3.441 Å) and π-π stacking interaction with a distance of 3.686 Å between the pyridin-2(1H)-one moieties.
